An international collaborative study on the detection of an HIV-1 genotype B field isolate by nucleic acid amplification techniques

Journal of Virological Methods

Volumn 78, Issue 1-2, 1999, Pages 21-34

  Bootman, J ^a   Heath, A B ^a   Hughes, P ^a   Holmes, H ^a  

^a NATIONAL INSTITUTE FOR BIOLOGICAL STANDARDS AND CONTROL   (United Kingdom)

Author keywords

HIV 1; Nucleic acid amplification techniques; PCR; Standardisation; Viral RNA

Indexed keywords

ANTIGEN P24;

ACCURACY; ANTIGEN DETECTION; ARTICLE; CONTROLLED STUDY; GENE AMPLIFICATION; GENOTYPE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN TISSUE; INTERMETHOD COMPARISON; LABORATORY; PRIORITY JOURNAL; RNA ANALYSIS; RNA SEQUENCE; STANDARDIZATION; TECHNIQUE; VIRUS CHARACTERIZATION;

ADULT; DNA, COMPLEMENTARY; DNA, VIRAL; HIV CORE PROTEIN P24; HIV INFECTIONS; HIV-1; HUMANS; INTERNATIONAL COOPERATION; LABORATORIES; MALE; NUCLEIC ACID AMPLIFICATION TECHNIQUES; POLYMERASE CHAIN REACTION; REPRODUCIBILITY OF RESULTS; RNA, VIRAL; SENSITIVITY AND SPECIFICITY;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0033052262     PISSN: 01660934     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-0934(98)00159-1     Document Type: Article

References (25)

1. Bootman J.S., Kitchin P.A. An international collaborative study to assess a set of reference reagents for HIV-1 PCR. J. Virol. Methods. 37:1992;23-42.
2. Bootman J.S., Kitchin P.A. Reference preparations in the standardisation of HIV-1 PCR - an international collaborative study. J. Virol. Methods. 49:1994;1-8.
3. Brettler D.B., Levine P.H. Factor concentrates for treatment of hemophilia: which one to choose? Blood. 73:1989;2067-2073.
4. Busch M.P., Lee L.L.L., Satten G.A., Henrard D.R., Farzadegan H., Nelson K.E., Read S., Dodd R.Y., Petersen L.R. Time course of detection of viral and serological markers preceding human immunodefiency virus type 1 seroconversion: implications for screening of blood and tissue donors. Transfusion. 35:1995;91-97.
5. Carpenter C.C.J., Fischl M.A., Hammer S.M., Hirsch M.S., Jacobsen D.M., Katzenstein D.A., Montaner J.S.G., Richman D.D., Saag M.S., Schooley R.T., Thompson M.A., Vella S., Yeni P.G., Volberding P.A. Antiretroviral therapy for HIV infection in 1996. J. Am. Med. Assoc. 276:1996;146-154.
6. Collet D. Modelling Binary Data. 1991;Chapman Hall, London.
7. Coste J., Montes B., Reynes J., Peeters M., Segarra C., Vendrell J.-P., Delaporte E., Segondy M. Comparative evaluation of three assays for the quantitation of human immunodeficiency virus type 1 RNA in plasma. J. Med. Virol. 50(4):1996;293-302.
8. Damen M., Cuypers H.T.M., Zaaijer H.L., Reesink H.W., Schaasberg W.P., Gerlich W.H., Niesters H.G.M., Lelie P.N. International collaborative study on the second EUROHEP HCV-RNA reference panel. J. Virol. Methods. 58:1996;175-185.
9. Debyser Z., van Wijngaerden E., van Laethem K., Beuselinck K., Reynders M., de Clercq E., Desmyter J., Vandamme A.-M. Failure to quantify viral load with two of the three commercial methods in a pregnant woman harboring an HIV type 1 subtype G strain. AIDS Res. Hum. Retrovir. 14(5):1998;453-459.
10. Donaldson Y.K., Bell J.E., Holmes E.C., Hughes E.S., Brown H.K., Simmonds P. In vivo distribution and cytopathology of variants of human immunodeficiency virus type 1 showing restricted sequence variability in the V3 loop. J. Virol. 68(9):1994;5991-6005.
11. Donaldson Y.K., Bell J.E., Ironside J.W., Brettle R.P., Robertson J.R., Busuttil A., Simmonds P. Redistribution of HIV outside the lymphoid system with onset of AIDS. Lancet. 343:1994;383-385.
12. Foster P.R., Cuthbertson B. Procedures for the prevention of virus transmission by blood products. Madhok R., Forbes C.D., Evatt B.L. Blood, Blood Products and HIV. 1993;207-248 Chapman and Hall Medical, London.
13. Kroner B.L., Rosenberg P.S., Aledort L.M., Alvord W.G., Goedert J.J. for the Multicentre Hemophilia Cohort Study. HIV-1 infection incidence among persons with hemophilia in the United States and Western Europe, 1978-1990. J. Acquired Immune Defic. Syndr. 7(3):1994;279-286.
14. Lelie, P.N., Cuypers, H.T.M., Rogers, P., Over, J., Schuitemaker, J., Quint, W.G.V., 1998. Standardisation of viral nucleic acid amplification methodology in blood safety testing: a risk-benefit analysis, submitted for publication.
15. Loussert-Ajaka I., Ly T.D., Chaix M.L., Ingrand D., Saragosti S., Courouce A.M., Brun-Vezinet F., Simon F. HIV-1/HIV-2 seronegativity in HIV-1 subtype O infected patients. Lancet. 343:1994;1393-1394.
16. Loussert-Ajaka I., Deschamps D., Simon F., Brun-Vezinet F., Ekwalanga M., Saragosti S. Genetic diversity and HIV detection by polymerase chain reaction. Lancet. 346:1995;912-913.
17. Manucci P.M., Santagostini E., Di Bona E., Gentili G., Ghirardini A., Schiavoni M., Mele A. The outbreak of hepatitis A in Italian patients with hemophilia: facts and fancies. Vox Sang. 67(Suppl. 1):1994;31-35.
18. Mellors J.W., Rinaldo C.R., Gupta P., White R.M., Todd J.A., Kingsley L.A. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science. 272:1996;1167-1170.
19. Nubling C.M., Willkommen H., Lower J. Hepatitis C transmission associated with intravenous immunoglobulins. Lancet. 345:1995;1174.
20. Petersen L.R., Satten G.A., Dodd R., Busch M., Kleinman S., Grindon A., Lenes B. Duration of time from onset of human immunodefiency virus type 1 infectiousness to development of detectable antibody. Transfusion. 34:1994;283-289.
21. Rogers P.M., Saldanha J., Allain J.P. Report of EPFA/NIBSC workshop 'Nucleic acid amplification tests (NAT) for the detection of blood-borne viruses'. Vox Sang. 72(4):1997;199-206.
22. Saag M.S., Holodniy M., Kuritzkes D.R., O'Brien W.A., Coombs R., Poscher M.E., Jacobsen D.M., Shaw G.M., Richman D.D., Volberding P.A. HIV viral load markers in clinical practice. Nat. Med. 2:1996;625-629.
23. Francis B., Green M, Payne C. The GLIM system, Release 4 Manual. 1993;Oxford Science, Oxford.
24. van Gemen B., Kievits T, Schukkink R., van Strijp D., Malek L.T., Sooknanan R., Huisman H.G., Lens P. Quantification of HIV-1 RNA in plasma using NASBA during HIV-1 primary infection. J Virol. Methods. 43:1993;177-188.
25. Vandamme A.-M., Schmit J.-C., Van Dooren S., Van Laethem K., Gobbers E., Kok W., Goubau P., Witvrouw M., Peetermans W., De Clercq E., Desmyter J. Quantification of HIV-1 RNA in plasma: comparable results with the NASBA HIV-1 RNA QT and the AMPLICOR HIV monitor test. J. AIDS Hum. Retrovir. 13:1996;127-139.